0001078782-17-000143.txt : 20170202 0001078782-17-000143.hdr.sgml : 20170202 20170202143519 ACCESSION NUMBER: 0001078782-17-000143 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170202 DATE AS OF CHANGE: 20170202 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Medifirst Solutions, Inc. CENTRAL INDEX KEY: 0001522704 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 273888260 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88979 FILM NUMBER: 17567873 BUSINESS ADDRESS: STREET 1: 4400 ROUTE 9 SOUTH STREET 2: SUITE 1000 CITY: FREEHOLD STATE: NJ ZIP: 07728 BUSINESS PHONE: 561-558-6872 MAIL ADDRESS: STREET 1: 4400 ROUTE 9 SOUTH STREET 2: SUITE 1000 CITY: FREEHOLD STATE: NJ ZIP: 07728 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SBI INVESTMENTS LLC 2014-1 CENTRAL INDEX KEY: 0001696987 IRS NUMBER: 471312022 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 369 LEXINGTON AVE STREET 2: 2ND FL CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-762-9971 MAIL ADDRESS: STREET 1: 369 LEXINGTON AVE STREET 2: 2ND FL CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G 1 f13g020217_sc13g.htm SCHEDULE 13G Schedule 13G


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13G


Under the Securities Exchange Act of 1934




Medifirst Solutions Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

58471B103

(CUSIP Number)

 

January 24, 2017

(Date of Event which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

      .  Rule 13d-1(b)

  X .  Rule 13d-1(c)

      .  Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.


The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).









 

 

 

 

 

CUSIP No. 58471B103

 

 

 

13G

 

 

 

 

 


 

 

 

 

 

1.

 

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)


SBI Investments LLC, 2014-1

EIN #: 47-1312022

  

 

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)          .

(b)      X .

 

 

 

3.

 

SEC USE ONLY

  

 

 

4.

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America, Delaware

  

 

 


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

 

5.

 

SOLE VOTING POWER


23,489,690 

  

 

6.

 

SHARED VOTING POWER


0

  

 

7.

 

SOLE DISPOSITIVE POWER


23,489,690

 

 

8.

 

SHARED DISPOSITIVE POWER


0

   


 

 

*Consists of Common Stock that the reporting person has the right to acquire by way of conversion of a security.

  

 

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


23,489,690

  

 

 

10.

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)          .

   

 

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


9.99%

 

 

 

12.

 

TYPE OF REPORTING PERSON (see instructions)


Accredited Investor

  

 

 

 

 

 

 

 





 

 

 

 

 

CUSIP No. 58471B103

 

 

 

13G

 

 

 

 

 

Item 1.


 

(a)

Name of Issuer
Medifirst Solutions Inc.

 

 

 

 

(b)

Address of Issuer’s Principal Executive Offices
4400 Route 9 South, Suite 1000.

Freehold, NJ 07728


Item 2.


 

(a)

Name of Person Filing
SBI Investments LLC, 2014-1

 

 

 

 

(b)

Address of the Principal Office or, if none, residence
369 Lexington Ave, 2nd Floor, New York, NY 10017

 

 

 

 

(c)

Citizenship
United States of America, Delaware

 

 

 

 

(d)

Title of Class of Securities
Common Stock

 

 

 

 

(e)

CUSIP Number
58471B103


Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


 

(a)

      .

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

 

 

 

 

(b)

      .

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(c)

      .

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(d)

      .

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

 

 

 

 

(e)

      .

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

 

 

 

 

(f)

      .

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

 

 

 

 

(g)

      .

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

 

 

 

 

(h)

      .

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

 

 

 

 

(i)

      .

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

 

 

 

 

(j)

      .

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

 

 






 

 

 

 

 

CUSIP No. 58471B103

 

 

 

13G

 

 

 

 

 

Item 4.  Ownership.


Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.


 

(a)

Amount beneficially owned:  23,489,690

 

 

 

 

 

(b)

Percent of class:   9.99%

 

 

 

 

 

(c)

Number of shares as to which the person has:  

 

 

 

 

 

 

(i)

Sole power to vote or to direct the vote  23,489,690

 

 

 

 

 

 

(ii)

Shared power to vote or to direct the vote 0

 

 

 

 

 

 

(iii)

Sole power to dispose or to direct the disposition of  23,489,690

 

 

 

 

 

 

(iv)

Shared power to dispose or to direct the disposition of  0

 

 

 

 

*Consists of Common Stock that the reporting person has the right to acquire by way of conversion of a security.


Item 5.  Ownership of Five Percent or Less of a Class.


If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following           ..


Item 6.  Ownership of More than Five Percent on Behalf of Another Person.


Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.


Item 8.  Identification and Classification of Members of the Group.


Item 9.  Notice of Dissolution of Group.


Item 10.  Certification.


 

(a)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):

 

 

 

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 

(b)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):

 

 

 

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 





 

 

 

 

 

CUSIP No. 58471B103

 

 

 

13G

 

 

 

 

 


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 

01/24/2017

Date

  

/s/ Peter Wisniewski

Signature

  

Peter Wisniewski/Manager

Name/Title